BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24100804)

  • 1. Clinical evaluation of systemic and local immune responses in cancer: time for integration.
    Gutkin DW; Shurin MR
    Cancer Immunol Immunother; 2014 Jan; 63(1):45-57. PubMed ID: 24100804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.
    Ladányi A
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):490-500. PubMed ID: 25818762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune cells in the tumor microenvironment.
    Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
    Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response regulation in the tumor microenvironment by hypoxia.
    Labiano S; Palazon A; Melero I
    Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of Basic Immunology for Clinical Investigators.
    Stephen B; Hajjar J
    Adv Exp Med Biol; 2017; 995():1-31. PubMed ID: 28321810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review.
    Ye Y; Xu C; Chen F; Liu Q; Cheng N
    Front Immunol; 2021; 12():771201. PubMed ID: 34899721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social networking of human neutrophils within the immune system.
    Scapini P; Cassatella MA
    Blood; 2014 Jul; 124(5):710-9. PubMed ID: 24923297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct innate lymphoid cell population regulates tumor-associated T cells.
    Crome SQ; Nguyen LT; Lopez-Verges S; Yang SY; Martin B; Yam JY; Johnson DJ; Nie J; Pniak M; Yen PH; Milea A; Sowamber R; Katz SR; Bernardini MQ; Clarke BA; Shaw PA; Lang PA; Berman HK; Pugh TJ; Lanier LL; Ohashi PS
    Nat Med; 2017 Mar; 23(3):368-375. PubMed ID: 28165478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
    Carnevalli LS; Ghadially H; Barry ST
    Front Immunol; 2021; 12():633685. PubMed ID: 33953710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
    Jackaman C; Nelson DJ
    Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immune Landscape in Women Cancers.
    Timperi E; Vissio E; Marchiò C; Romano E
    Cancer Treat Res; 2020; 180():215-249. PubMed ID: 32215872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
    Albini A; Bruno A; Noonan DM; Mortara L
    Front Immunol; 2018; 9():527. PubMed ID: 29675018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune contexture of cholangiocarcinoma.
    Paillet J; Kroemer G; Pol JG
    Curr Opin Gastroenterol; 2020 Mar; 36(2):70-76. PubMed ID: 31895228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tumor Microenvironment Innately Modulates Cancer Progression.
    Hinshaw DC; Shevde LA
    Cancer Res; 2019 Sep; 79(18):4557-4566. PubMed ID: 31350295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of tumor-infiltrating immune cells in melanoma].
    Ladányi A
    Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.